Hereditary haemorrhagic telangiectasia: a questionnaire based study to delineate the different phenotypes caused by endoglin and ALK1 mutations
Open Access
- 1 August 2003
- journal article
- research article
- Published by BMJ in Journal of Medical Genetics
- Vol. 40 (8), 585-590
- https://doi.org/10.1136/jmg.40.8.585
Abstract
Background: Hereditary haemorrhagic telangiectasia (HHT) is an autosomal dominant vascular dysplasia characterised by mucocutaneous telangiectasis, epistaxis, gastrointestinal haemorrhage, and arteriovenous malformations in the lung and brain. Causative mutations for HHT have been identified in two genes, endoglin and ALK1, which encode proteins involved in serine-threonine kinase signalling in the endothelial cell. Methods: A number of people affected with HHT had completed a postal questionnaire as part of an international study to delineate the HHT phenotype. We identified questionnaires completed by subjects in whom we had identified a mutation in endoglin or ALK1. Further questionnaires were sent to families with known mutations. Data were only included from questionnaires returned by people known to carry disease causing mutations. Results: Questionnaires were completed by 83 subjects with known mutations. Of these, 49 had endoglin mutations (HHT1) and 34 had ALK1 mutations (HHT2). Subjects with HHT1 reported an earlier onset of epistaxis (p=0.01) and telangiectasis (p=0.0001) than those with HHT2. Pulmonary arteriovenous malformations were only reported in the endoglin mutation group in our study (pConclusions: Our questionnaire based study provides evidence that the HHT phenotype caused by mutations in endoglin (HHT1) is distinct from, and more severe than, HHT caused by mutations in ALK1 (HHT2). This has significant implications for diagnosis, screening, and treatment in the two different forms of HHT, as well as for understanding the pathogenesis of the disease.Keywords
This publication has 41 references indexed in Scilit:
- Extracellular and Cytoplasmic Domains of Endoglin Interact with the Transforming Growth Factor-β Receptors I and IIJournal of Biological Chemistry, 2002
- Dysregulation of transforming growth factor β signaling in scleroderma: Overexpression of endoglin in cutaneous scleroderma fibroblastsArthritis & Rheumatism, 2002
- Endoglin overexpression modulates cellular morphology, migration, and adhesion of mouse fibroblastsEuropean Journal of Cell Biology, 1999
- Expression of Endoglin mRNA and Protein in Human Vascular Smooth Muscle CellsBiochemical and Biophysical Research Communications, 1998
- Hepatic vascular malformations in hereditary hemorrhagic telangiectasia: Doppler sonographic screening in a large familyJournal of Hepatology, 1997
- Clinical heterogeneity in hereditary haemorrhagic telangiectasia: are pulmonary arteriovenous malformations more common in families linked to endoglin?Journal of Medical Genetics, 1996
- Hereditary hemorrhagic telangiectasia: A disorder in search of the genetics communityAmerican Journal of Medical Genetics, 1994
- An Association Between Migrainous Aura and Hereditary Haemorrhagic TelangiectasiaHeadache: The Journal of Head and Face Pain, 1993
- Hereditary haemorrhagic telangiectasia: a clinical analysis.Journal of Medical Genetics, 1992
- Pulmonary Arteriovenous Fistulas in Hereditary Hemorrhagic TelangiectasiaActa Medica Scandinavica, 1985